Horizon Pharma to buy Hyperion Therapeutics
March 30, 2015 at 14:24 PM EDT
Horizon
Pharma (Nasdaq: HZNP) will pay a premium of approximately $1.1 billion
in cash to buy Hyperion Therapeutics Inc. (Nasdaq: HPTX). Shares of
Horizon soared $3.28 to $25.09 while Hyperion stock climbed $3.36 to
$46.10.